ASTRAZENECA PLC ADS AZN (NYSE)

(NEW YORK)Shares of large pharmaceutical companies lacked direction in early Friday trading. The broader market slipped as investors digested new record highs for oil and a surprising jump i...READ MORE

(WASHINGTON)The global market for cancer drugs will grow twice as fast as that for all other pharmaceuticals as the developing world spends more on health care, a new report says.READ MORE

(LONDON)AstraZeneca PLC said Wednesday that U.S. regulators have approved its anti-psychotic drug Seroquel as a maintenance treatment for patients with a type of bipolar disorder.READ MORE

(CHAPEL HILL, N.C.)Drug developer Pozen Inc. on Thursday raised its outlook for 2008 revenue to between $62 million and $68 million, well above Wall Street estimates. Analysts polled by Thomson Finan...READ MORE

(CHAPEL HILL, N.C.)Drug developer Pozen Inc. said Thursday that its first-quarter loss more than tripled on higher operating expenses, though the loss was in-line with Wall Street estimates.READ MORE

(NEW YORK)Shares of OSI Pharmaceuticals rose Wednesday, a day after the biotechnology company beat Wall Street expectations on higher sales of its cancer drug Tarceva.READ MORE

(LONDON)AstraZeneca PLC said Tuesday that a European patent has been revoked covering the use of its Symbicort medicine as a treatment for a condition commonly known as "smoker's cough."READ MORE